Servier India Private Limited

Servier India Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U52310MH1985PTC037001 Incorporated 30 July 1985 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹685.38 Cr
▲ 35% YoY
Net profit · FY 2025
₹308.98 Cr
Net margin 45.1%
EBITDA · FY 2025
₹144.66 Cr
EBITDA margin 21.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.76 Cr
Issued & subscribed
Open charges
₹4 Cr
Satisfied ₹3 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
525
Provident fund records

About Servier India Private Limited

Data last updated:

Servier India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Servier International B.V.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 July 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52310MH1985PTC037001. Its GSTIN is 27AAACS6696R1ZB (Maharashtra). The company holds 8 GST registrations, of which 7 are active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.76 Cr. It was formerly known as Serdia Pharmaceuticals India Limited and Serdia Pharmaceuticals India Private Limited. It is led by directors including Aurelien Breton (Managing Director) and Bradley Ryan Lloyd.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹685.38 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹308.98 Cr (net margin 45.1%) and EBITDA of ₹144.66 Cr (EBITDA margin 21.1%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 16% over five years.

The company has about 525 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 3 brands: Angina Awareness India, Jay Pharma and Servier. As per MCA filings, the company has open charges of ₹4 Cr and satisfied charges of ₹3 Cr on record. Court records list 17 cases involving the company, including 11 filed by the company and 6 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website servier.com.

Company details

CIN U52310MH1985PTC037001
Registration Number 037001
Incorporation Date 30 July 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Servier International B.V.
Compliance Status Active Compliant

Name history

Servier India has undergone 2 name changes throughout its history. The company was previously known as Serdia Pharmaceuticals India Limited, and Serdia Pharmaceuticals India Private Limited. The current legal name is Servier India Private Limited.

Company NameStatus
Servier India Private LimitedCurrent
Serdia Pharmaceuticals India LimitedPrevious
Serdia Pharmaceuticals India Private LimitedPrevious

Contact details

Servier India Private Limited's registered office is in Mumbai, Maharashtra. Its website is servier.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    17th Floor Crescenzo Business District B Wing Plot Nos C – 38&C – 39, G Block Behind Mca BKC Bandra East, Mumbai, Maharashtra, India – 400051
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Servier India Private Limited, buy the company report.

Comprehensive company report
Servier India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Servier India operates multiple associated brands including Angina Awareness India, Jay Pharma, and Servier. Each brand links to its own profile.

BrandDescriptionWebsite
Educational platform offering angina information, diagnosis tips, and heart disease resources.anginaawarenessindia.com
Pharmaceutical products are distributed by Jay Pharma in India.jaypharma.com
Pharmaceutical therapies for cancers and neurological disorders are developed.servier.com

Business activity

The main business activity of Servier India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Servier India Private Limited, buy the company report.

Financials of Servier India Private Limited

FY 2024 filings available

Servier India Private Limited reported revenue of ₹685.38 Cr (up 35% YoY) for FY 2025.

Revenue · FY 2025
₹685.38 Cr ▲ 35%
Net profit · FY 2025
₹308.98 Cr margin 45.1%
EBITDA · FY 2025
₹144.66 Cr margin 21.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 19%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 83%
3 years · compounded
▲ 32%
5 years · compounded
▲ 27%

Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 35% growth in the latest year. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹144.66 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹308.98 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin21.1%
Net Profit Margin45.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Servier India Private Limited, buy the company report.

Board of directors of Servier India Private Limited

Servier India has 3 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bradley Ryan LloydDirector26 Sep 20233 Years 1 MonthsCurrent
Pierre Jean Bernard AndriotDirector18 Dec 201312 Years 10 MonthsCurrent
Aurelien BretonManaging Director23 Sep 20242 Years 1 MonthsCurrent

Peer comparison

Servier India Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Fourrts (India) Laboratories Private Limited₹760.55 Cr (FY 2024)7.0%Chennai, Tamil Nadu, India
Pritam International Private Limited₹758.46 Cr (FY 2025)15.0%Kolkata, West Bengal, India
Indchemie Health Specialities Private Limited₹734.44 Cr (FY 2025)5.0%Mumbai, Maharashtra, India
Sanofi-Synthelabo (India) Private Limited₹729.49 Cr (FY 2020)16.0%Mumbai, Maharashtra, India
Apotex Research Private Limited₹727.34 Cr (FY 2025)22.0%Jigani Hobli, Karnataka, India
Servier India Private Limitedthis company₹685.38 Cr (FY 2025)₹308.98 Cr45.1%35.0%525Mumbai, Maharashtra, India
Wallace Pharmaceuticals Private Limited₹673.06 Cr (FY 2025)16.0%Goa, India
Venus Remedies Limited₹668.84 Cr (FY 2025)9.0%Chandigarh, India
Tablets (India) Ltd₹667.39 Cr (FY 2025)9.0%Chennai, Tamil Nadu, India
RPG Life Sciences Limited₹666.11 Cr (FY 2025)13.0%Mumbai, Maharashtra, India

To see the full peer comparison of Servier India Private Limited, buy the company report.

Auditor

Servier India Private Limited is audited by SRBC & CO LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SRBC & CO LLPFY 2023324982E/E300003

Shareholding

The shareholding of Servier India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Servier India Private Limited, buy the company report.

Charges & borrowings

Open charges
₹4 Cr
Satisfied charges
₹3 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹4.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Jul 2016100039539Hdfc Bank Limited₹4 CrOpen
02 Apr 198690211499Societe Generale₹3 CrSatisfied

To see the full charge records of Servier India Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

Servier India Private Limited has 9 MSME Form 1 returns on record between 2020 and 2023, listing 132 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 34)

SupplierAmount dueDue sinceReported on
Reema Transport Private Limited
an individual supplier
Stepperr Corporate Supplies LLP
Sunshine Organics Pvt Ltd
Core Analyticals Private Limited

To see the full MSME payment records of Servier India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Servier India has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Servier Pharmaceuticals (India) Private LimitedU51397MH1998PTC116694

To see the full group structure of Servier India Private Limited, buy the company report.

Employees & EPFO

Servier India Private Limited has a workforce of 525 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.

Employee count
525
Active EPFO establishments
1
Employee growth
1.55%

GST

Servier India has 8 GST registrations: 7 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
8
Active
7
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACS6696R1ZBMaharashtraActive01 Jul 2017
09AAACS6696R1Z9Uttar PradeshActive01 Jul 2017
19AAACS6696R1Z8West BengalActive25 May 2018
36AAACS6696R1ZCTelanganaActive25 May 2018

To see the full GST registrations and return filing status of Servier India Private Limited, buy the company report.

Recent activity

Servier India Private Limited has 17 board changes on record since 2008: 3 appointments and 14 cessations. The latest: Aurelien Breton ceased to be Additional Director on 29 Sep 2024.

AGM
Servier India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Aurelien Breton ceased to be Additional Director.
Appointed
Aurelien Breton was appointed as Managing Director.
Filing
Servier India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Bradley Ryan Lloyd ceased to be Additional Director.
Appointed
Bradley Ryan Lloyd was appointed as Director.
Ceased
Bernard Parrin ceased to be Director.
Ceased
Glen Lingam Ramalingam ceased to be Additional Director.
Ceased
Philippe Louis Marc Malet ceased to be Director.
Ceased
Geeta Mahadeo Karnik ceased to be Company Secretary.
Ceased
Pierre Perez ceased to be Additional Director.
Ceased
Georges Jabre ceased to be Director.

13 earlier events are in the company report.

Frequently asked questions

Servier India is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 July 1985 (41+ years old) and is registered under CIN U52310MH1985PTC037001.

Servier India has 3 current directors:

The latest financial statements of Servier India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Servier India is 27AAACS6696R1ZB, registered in Maharashtra. The company has 8 GST registrations in all, of which 7 are active and 1 is cancelled or inactive. Other active GSTINs include 09AAACS6696R1Z9 (Uttar Pradesh), 19AAACS6696R1Z8 (West Bengal), 36AAACS6696R1ZC (Telangana).

The CIN (Corporate Identification Number) of Servier India is U52310MH1985PTC037001. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Servier India has 17 court cases on record: 11 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.

Servier India was incorporated on 30 July 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Servier India by revenue are Fourrts (India) Laboratories Private Limited, Pritam International Private Limited, Indchemie Health Specialities Private Limited, Sanofi-Synthelabo (India) Private Limited, Apotex Research Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Aurelien Breton ceased to be Additional Director on 29 Sep 2024. Aurelien Breton was appointed as Managing Director on 23 Sep 2024. Bradley Ryan Lloyd ceased to be Additional Director on 29 Sep 2023. Servier India has 17 board changes on record in total.

Servier India has 9 MSME Form 1 returns on record between 2020 and 2023, listing 132 overdue payments to 34 micro and small suppliers. The latest return was filed on 29 Aug 2023.

Servier India can be reached through the website servier.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Servier India is at 17th Floor Crescenzo Business District B Wing Plot Nos C – 38&C – 39, G Block Behind Mca BKC Bandra East, Mumbai, Maharashtra, India – 400051.